You are already subscribed with the entered email address.

Your e-mail address is known to us, but you are inactive in the receipt list. We have sent you a confirmation email with an activation link to reactivate your account and receive the newsletter in the future.

You have signed up for the newsletter and receive a confirmation email on your entered email address containing an activation link that you must follow to confirm your application.
It may take a few minutes before you receive this email.

Slide background

Basic PharmaFocused
on the future

ProductsBusiness Development

Slide background

Basic PharmaFocused
on the future




Our commercial partners rely on our skills and expertise. Our people are committed to realise your goals and enable you to make use of our comprehensive knowledge and technology platform. Read more

Progress in Personalised Medicine developing a novel biopharmaceutical, from bench to production - May 16 - 2019

Read more

Basic Pharma meets EU serialisation requirements...

Early start enables Basic Pharma to be compliant in time with the EU Falsified Medicines Directive

Read more

Implementing the Falsified Medicines Directive at ...

On February 9th2016, Mr. Juncker, president of the European Union, signed the Delegated Act to the Falsified Medicines Directiv...
Read more

Basic Pharma trusts Arvato Systems to Implement th...

Production serialization in the pharmaceutical industry. - Arvato Systems and Basic Pharma sign a contract on implementing the ...
Read more

Basic Pharma
Contact us via email or phone or come by our office!
phone+31 (0)88 255 40 10


Burgemeester Lemmensstraat 352
P.O. Box 1124
6160 BC Geleen
The Netherlands

In the event of an urgent safety issue,
please contact us:

+31 (0)88 255 40 60

You can report any suspected adverse drug reactions / side effects of our medications by sending an email to:


When using navigation systems. Use the address: Koestraat 1, 6167 RA, Geleen
Get directions

© 2019 | All rights reserved | Basic Pharma | Privacy Statement | Design and development